This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Bayer Schering Pharma Ag, Schering Aktiengesellschaft, Bayer Healthcare LLC. Active years: 1999-2017.
Company Filing History:
6 out of 192 
3 out of 1,409 
1 out of 789 
Years Active: 1999-2017
Title: Douglas W Schneider: Innovator in Antibody Technology
Introduction
Douglas W Schneider is a prominent inventor based in Lafayette, CA (US), known for his significant contributions to the field of antibody technology. With a total of 11 patents to his name, Schneider has made remarkable advancements that have implications for diagnostics and therapeutics.
Latest Patents
One of his latest patents focuses on monospecific and multispecific antibodies and their methods of use. This invention relates to antibodies that can be utilized for the diagnosis and treatment of various diseases. Additionally, these antibodies may be modified by protease cleavage, with protease control or regulation provided by a protease site located in a linker. These protease-regulated antibodies hold promise for further applications in disease diagnosis and treatment. Another notable patent involves dimeric molecular complexes that are useful for diagnostics and therapeutics.
Career Highlights
Throughout his career, Douglas W Schneider has worked with leading companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Schering Aktiengesellschaft. His work has significantly impacted the development of innovative medical solutions.
Collaborations
Schneider has collaborated with notable professionals in his field, including Renate Parry and Richard N Harkins. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Douglas W Schneider's work in antibody technology exemplifies the innovative spirit of modern science. His contributions continue to pave the way for advancements in medical diagnostics and treatment options.